Brief: Pangenomic Health Subsidiary, MUJN Diagnostics, Announces The Engagement Of Hemex Health To Assist In The Development Of Brain Health Diagnostics System
30/03/2023 12:37
March 30 (Reuters) - Pangenomic Health Inc NARA.CD :
* PANGENOMIC HEALTH SUBSIDIARY, MUJN DIAGNOSTICS, ANNOUNCES
THE
ENGAGEMENT OF HEMEX HEALTH TO ASSIST IN THE DEVELOPMENT OF BRAIN
HEALTH DIAGNOSTICS SYSTEM
Source text for Eikon: ID:nCNW9q6Cca
Further company coverage: NARA.CD
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Pangenomic Health
See all newsBrief: Pangenomic Health Announces Withdrawal From AQSE
PanGenomic Health Inc: PanGenomic Health Announces Withdrawal from AQSE
Brief: Pangenomic Health Signs Letter Of Intent With Crescita Capital For $5 Mln Equity Drawdown Facility
PanGenomic Health Inc: PanGenomic Health Signs Letter of Intent with Crescita Capital for $5 Million Equity Drawdown Facility
PanGenomic Health Inc: PanGenomic Health Announces Q3 Financial Results